Vident Advisory LLC Has $4.68 Million Stake in Intuitive Surgical, Inc. (NASDAQ:ISRG)

Vident Advisory LLC grew its holdings in shares of Intuitive Surgical, Inc. (NASDAQ:ISRG) by 11.2% in the 4th quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 8,972 shares of the medical equipment provider’s stock after acquiring an additional 904 shares during the quarter. Vident Advisory LLC’s holdings in Intuitive Surgical were worth $4,684,000 at the end of the most recent quarter.

Several other institutional investors have also recently bought and sold shares of ISRG. Atala Financial Inc bought a new stake in shares of Intuitive Surgical during the fourth quarter worth about $25,000. Berbice Capital Management LLC bought a new stake in shares of Intuitive Surgical during the fourth quarter worth about $26,000. Parvin Asset Management LLC bought a new stake in shares of Intuitive Surgical during the fourth quarter worth about $26,000. BankPlus Trust Department bought a new stake in shares of Intuitive Surgical during the fourth quarter worth about $28,000. Finally, Hurley Capital LLC bought a new stake in shares of Intuitive Surgical during the fourth quarter worth about $28,000. Institutional investors and hedge funds own 83.64% of the company’s stock.

Intuitive Surgical Stock Performance

Shares of ISRG opened at $557.16 on Wednesday. Intuitive Surgical, Inc. has a 52-week low of $396.15 and a 52-week high of $616.00. The business’s 50 day moving average price is $508.11 and its two-hundred day moving average price is $537.36. The firm has a market cap of $199.70 billion, a PE ratio of 86.92, a price-to-earnings-growth ratio of 5.85 and a beta of 1.70.

Intuitive Surgical (NASDAQ:ISRG) last issued its quarterly earnings results on Tuesday, April 22nd. The medical equipment provider reported $1.81 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.71 by $0.10. Intuitive Surgical had a return on equity of 14.55% and a net margin of 27.81%. The firm had revenue of $2.25 billion for the quarter, compared to analyst estimates of $2.19 billion. During the same period in the previous year, the firm earned $1.50 earnings per share. Research analysts predict that Intuitive Surgical, Inc. will post 6.43 EPS for the current fiscal year.

Insider Buying and Selling at Intuitive Surgical

In other news, EVP Myriam Curet sold 2,401 shares of the company’s stock in a transaction that occurred on Thursday, February 27th. The stock was sold at an average price of $581.00, for a total transaction of $1,394,981.00. Following the transaction, the executive vice president now directly owns 353 shares of the company’s stock, valued at $205,093. This represents a 87.18% decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. Also, CFO Jamie Samath sold 188 shares of the company’s stock in a transaction that occurred on Friday, February 28th. The stock was sold at an average price of $566.94, for a total value of $106,584.72. Following the transaction, the chief financial officer now directly owns 7,162 shares in the company, valued at $4,060,424.28. The trade was a 2.56% decrease in their ownership of the stock. The disclosure for this sale can be found here. Over the last three months, insiders have sold 32,700 shares of company stock valued at $16,865,621. 0.70% of the stock is currently owned by company insiders.

Analyst Ratings Changes

ISRG has been the topic of several research reports. Raymond James boosted their price target on Intuitive Surgical from $560.00 to $688.00 and gave the stock an “outperform” rating in a report on Friday, January 24th. UBS Group boosted their price target on Intuitive Surgical from $500.00 to $560.00 and gave the stock a “neutral” rating in a report on Monday, January 27th. Truist Financial reduced their price target on Intuitive Surgical from $605.00 to $590.00 and set a “buy” rating on the stock in a report on Wednesday, April 23rd. CICC Research started coverage on Intuitive Surgical in a report on Monday, January 27th. They issued a “neutral” rating and a $550.00 target price on the stock. Finally, Erste Group Bank cut Intuitive Surgical from a “strong-buy” rating to a “hold” rating in a report on Monday, March 17th. Five analysts have rated the stock with a hold rating and fifteen have given a buy rating to the company’s stock. According to MarketBeat.com, Intuitive Surgical presently has a consensus rating of “Moderate Buy” and a consensus target price of $598.95.

Intuitive Surgical Company Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.